Cargando…

Use of the SAMe-TT(2)R(2) Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence

BACKGROUND: The efficacy and safety of warfarin therapy for stroke prevention in atrial fibrillation (AF) depends on the time in therapeutic range (TTR). We aimed to assess the predictive ability of SAMe-TT(2)R(2) score in Chinese AF patients on warfarin, whose TTR is notoriously poor. METHODS AND R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Pak Hei, Hai, Jo Jo, Chan, Esther W., Li, Wen Hua, Tse, Hung Fat, Wong, Ian C. K., Lip, Gregory Y. H., Siu, Chung Wah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807017/ https://www.ncbi.nlm.nih.gov/pubmed/27010633 http://dx.doi.org/10.1371/journal.pone.0150674

Ejemplares similares

Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015)

The SAMe-TT(2)R(2) Score Predicts Warfarin Control in an Australian Population with Atrial Fibrillation
por: Bernaitis, Nijole, et al.
Publicado: (2019)

Effect of SAMe-TT(2)R(2) score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
por: Elewa, Hazem, et al.
Publicado: (2020)

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score
por: Methavigul, Komsing, et al.
Publicado: (2023)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study
por: Liu, Shin-Huei, et al.
Publicado: (2023)

PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights
por: Chan, Yap-Hang, et al.
Publicado: (2017)

Evaluation of the Validity of SAMe-TT(2)R(2) Score in a Cohort of Venous Thromboembolism Patients Treated With Warfarin
por: Alhmoud, Eman Nawash, et al.
Publicado: (2020)

Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023)

Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin
por: Hai, Jo-Jo, et al.
Publicado: (2019)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
por: Krejczy, Martin, et al.
Publicado: (2015)

Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment
por: Zhao, Jiaxi, et al.
Publicado: (2021)

Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry
por: Hai, Jo-Jo, et al.
Publicado: (2016)

Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
por: Ho, Mei Han, et al.
Publicado: (2014)

Editorial to “Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation”
por: Lau, Chu‐Pak, et al.
Publicado: (2020)

SAMe-TT(2)R(2) Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events
por: Pivatto Júnior, Fernando, et al.
Publicado: (2017)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT(2)R(2) score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol
por: Phrommintikul, Arintaya, et al.
Publicado: (2021)

Evaluation of ABC Bleeding Score and SAMe-TT2R2 Score on the Risk of Bleeding after Anticoagulation in Patients with Nonvalvular Atrial Fibrillation Complicated with Coronary Heart Disease
por: Du, Meiling, et al.
Publicado: (2022)

Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention
por: Chan, Pak-Hei, et al.
Publicado: (2016)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
por: Choi, Jiyoon C, et al.
Publicado: (2014)

Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016)

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
por: Lip, Gregory Y. H., et al.
Publicado: (2018)

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
por: Tsai, Chuan-Tsai, et al.
Publicado: (2020)

Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
por: Chan, Pak-Hei, et al.
Publicado: (2013)

Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study
por: Cheung, Ching-Lung, et al.
Publicado: (2021)

Lack of Association of Clinical Factors (SAMe-TT(2)R(2)) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality
por: Park, Yun Kyung, et al.
Publicado: (2015)

Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
por: Bahbahani, Hamad, et al.
Publicado: (2018)

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation—The EWA study
por: Jaakkola, Samuli, et al.
Publicado: (2017)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
por: Lee, Hsin‐Fu, et al.
Publicado: (2019)

Resveratrol stereoselectively affected (±)warfarin pharmacokinetics and enhanced the anticoagulation effect
por: Huang, Tse-Yin, et al.
Publicado: (2020)

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
por: Larsen, Torben Bjerregaard, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iqpgfapbjc69br72h28cful6lr